Nasometin (Mometasone Furoate)

Mometasone furoate is a potent glucocorticoid receptor agonist. By binding to intracellular glucocorticoid receptors in nasal mucosal cells, it suppresses the transcription of pro‑inflammatory cytokines, chemokines, and other mediators, leading to decreased swelling and mucus production in the nasal passages.

The specific dosing regimen for Nasometin is set by the prescribing clinician based on the patient’s age, severity of symptoms, and response to therapy. Typical adult dosing may involve one or two sprays per nostril once daily, but the exact number of sprays and frequency should follow the prescriber’s instructions.

The safety of mometasone furoate nasal spray in pregnancy or while breastfeeding has not been definitively established. Healthcare providers usually weigh the potential benefits against any possible risks, and may recommend alternative treatments if concerns arise. Patients should discuss their individual situation with a qualified professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Nasometin. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Nasometin (mometasone furoate) is a high‑potency, once‑daily nasal corticosteroid, similar in efficacy to fluticasone and budesonide but often distinguished by its low systemic absorption and favorable safety profile. Choice of agent depends on factors such as patient preference, device type, cost, and specific clinical response.

Nasometin should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the spray bottle tightly closed when not in use, and avoid exposing it to extreme temperatures that could affect the formulation’s stability.

Before each use, gently shake the bottle and prime it if it is the first use. Tilt the head slightly forward, insert the nozzle into one nostril, and close the opposite nostril with a finger. Press the actuator to deliver the prescribed number of sprays, then repeat in the other nostril if directed. Avoid blowing the nose immediately after administration.

Although rare, serious adverse events can include nasal septal perforation, severe allergic reactions such as anaphylaxis, and systemic effects like adrenal suppression or ocular complications. Patients should seek immediate medical attention if they experience unusual bleeding, vision changes, severe headache, or signs of an allergic reaction.

Nasometin is contraindicated in individuals with known hypersensitivity to mometasone furoate or any component of the formulation. It should also be avoided in patients with active nasal infections, recent nasal surgery, or trauma until cleared by a physician. Consultation with a healthcare professional is essential before initiating therapy.